These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9795832)

  • 1. Endogenous relatives of ADP-ribosylating bacterial toxins in mice and men: potential regulators of immune cell function.
    Haag F; Koch-Nolte F
    J Biol Regul Homeost Agents; 1998; 12(3):53-62. PubMed ID: 9795832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins.
    Koch-Nolte F; Haag F; Braren R; Kühl M; Hoovers J; Balasubramanian S; Bazan F; Thiele HG
    Genomics; 1997 Feb; 39(3):370-6. PubMed ID: 9119374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells.
    Koch-Nolte F; Adriouch S; Bannas P; Krebs C; Scheuplein F; Seman M; Haag F
    Ann Med; 2006; 38(3):188-99. PubMed ID: 16720433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono(ADP-ribosyl)transferases and related enzymes in animal tissues. Emerging gene families.
    Koch-Nolte F; Haag F
    Adv Exp Med Biol; 1997; 419():1-13. PubMed ID: 9193631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium.
    Alzogaray V; Danquah W; Aguirre A; Urrutia M; Berguer P; García Véscovi E; Haag F; Koch-Nolte F; Goldbaum FA
    FASEB J; 2011 Feb; 25(2):526-34. PubMed ID: 20940265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the mono(ADP)ribosylation of proteins in cellular regulation].
    Nemchinskaia VL
    Tsitologiia; 1988 Feb; 30(2):115-26. PubMed ID: 3131935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori induces mono-(adenosine 5'-diphosphate)-ribosylation in human gastric adenocarcinoma.
    Akai T; Nabeya Y; Yahiro K; Morinaga N; Mitsuhashi K; Inoue M; Sakamoto A; Ochiai T; Noda M
    Int J Oncol; 2006 Oct; 29(4):965-72. PubMed ID: 16964392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
    Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
    J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
    Barth H; Blöcker D; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and target proteins of arginine-specific mono-ADP-ribosylation in T-tubules of rabbit skeletal muscle.
    Klebl BM; Göpel SO; Pette D
    Arch Biochem Biophys; 1997 Nov; 347(2):155-62. PubMed ID: 9367520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The best defense is a good offense--Salmonella deploys an ADP-ribosylating toxin.
    Lesnick ML; Guiney DG
    Trends Microbiol; 2001 Jan; 9(1):2-4; discussion 4-5. PubMed ID: 11166220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity of soluble and membrane-associated ADP-ribosyltransferase ART2.1.
    Zheng X; Morrison AR; Chung AS; Moss J; Bortell R
    J Cell Biochem; 2006 Jul; 98(4):851-60. PubMed ID: 16453289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
    Holbourn KP; Shone CC; Acharya KR
    FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial ADP-ribosylating toxins: molecular structures and signal transducing functions.
    Kato I
    Microbiol Immunol; 1991; 35(5):349-59. PubMed ID: 1943847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling.
    Corda D; Di Girolamo M
    Sci STKE; 2002 Dec; 2002(163):pe53. PubMed ID: 12488509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K; Bektaş M; Gökçe S; Nurten R
    Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mono(ADP-ribosyl)ation of 2'-deoxyguanosine residue in DNA by an apoptosis-inducing protein, pierisin-1, from cabbage butterfly.
    Takamura-Enya T; Watanabe M; Totsuka Y; Kanazawa T; Matsushima-Hibiya Y; Koyama K; Sugimura T; Wakabayashi K
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12414-9. PubMed ID: 11592983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.
    Vogelsgesang M; Pautsch A; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):347-60. PubMed ID: 17146673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.